Case File
efta-02561062DOJ Data Set 11OtherEFTA02561062
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02561062
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <jeevacation@gmail.com>
Sent:
Saturday, September 29, 2012 3:43 AM
To:
Eileen Alexanderson
Subject:
Re: FW: Foreign Disclosures - Phaidon
passive advice„ , understood. what about casino control? any furt=er issues
On Fri, Sep 28, 2012 at 5:05 P=, Eileen Alexanderson <EAlexanderson@apollo-advisors.com<=a»
<mailto:EAlexanderso=@apollo-advisors.com> wrote:
From: Thomas Tur=in Imailto:TTurrin@rem=co.com <mailto:TTurrin@rem-co.com> j
Sent: Friday, September 28, =012 4:22 PM
To: Eileen Alexanderson
Subject: Foreign Disclosures=- Phaidon
Eileen,
The attached memo is a brief overview of the major foreign disclosure requireme=ts to be made
by Leon on his personal income tax returns relating to the Phaidon acquisition. I will review the disclosure
requirements in detail with counsel after the closing. It may be that other disclosures may be necessary
depending on the ultimate elections that are made by the various entities and upon re=iew of the final closing
documents and discussion with counsel.
If you or Leon has any questions, I am available anytime.
EFTA_R1_01722362
EFTA02561062
Best,
Tom
THO=AS TURRIN, CPA
Par=ner
Raich Ende Malter & Co. LLP
1375 Broadway
New Y=rk, New York 10018
(212)944-4433 <tel:%282=2%29944-4433> (e=t 404)
(212)389-9816 <tel:%282=2%29389-9816> (=irect line)
(212)944-5404 <tel:%282=2%29944-5404> (=ax)
(917)670-4231 <tel:%289=7%29670-4231> (=ell)
Email: tturrin@rem-co.com<=u>
Website: www.rem-co.com</=>
=u>
=A0
CONFIDENTIALITY STATEME=T: The i=formation contained in this electronic communication, including any and
all attachments and enclosures, may be privileged and is strictly confidential, intended solely for the use of the person(s)
identif=ed above to receive this communication. If you are not the person(s) identifie= above to receive this
communication, you are hereby notified that you may n=t disclose print, copy, disseminate, or otherwise use the
information contain=d herein. If you are an employee or agent of the person(s) identified above t= receive this
communication and, as such, you have been authorized to delive= this communication to such person(s), you may
disclose, print, copy, disseminate, or otherwise use the information contained in this communicati=n solely for the
2
EFTA_R1_01722363
EFTA02561063
purpose of such delivery. Unauthorized interception and/or u=e of this communication are/is strictly prohibited and may
be punishable by l=w. If you have received this communication in error, please reply and notify t=e sender (only) of that
fact and delete the communication, including any and =11 attachments and enclosures, from your computer or other
electronic device o= which you may have received this communication.=/p>
CIRCULAR 230 DISCLOSURE= To insure compliance with requirements imposed by the Internal Revenue Service=
we inform you that any tax advice contained in this communication (including a=y and all attachments), unless expressly
stated otherwise, was not intended o= written to be used and cannot be used for the purpose of (i) avoiding tax-related
penalties imposed by the Internal Revenue Code or (ii) promotin=, marketing, or recommending to another party any
transaction(s) or tax-relat=d matter(s) addressed herein. This communication may not be forwarded (other =han to the
addressee(s) identified above) without our express written consent.<=>
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged
material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
information by persons or entities other than the intended
recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
The information contained in =his communication is confidential, may be attorney-client privileged, m=y constitute
inside information, and is intended only for the use of the a=dressee. It is the property of Jeffrey Epstein Unauthorized
use, di=closure or copying of this communication or any part thereof is strictl= prohibited and may be unlawful. If you
have received this communication in error, p=ease notify us immediately by return e-mail or by e-mail to
jeevacation@gmail.com, =nd destroy this communication and all copies thereof, including all attachm=nts. copyright -all
rights reserved
3
EFTA_R1_01722364
EFTA02561064
Technical Artifacts (15)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.rem-co.comEmail
ealexanderson@apollo-advisors.comEmail
jeevacation@gmail.comEmail
tturrin@rem-co.comPhone
(212)389-9816Phone
(212)944-4433Phone
(212)944-5404Phone
(917)670-4231Phone
2561062Phone
2561063Phone
2561064Phone
389-9816Phone
670-4231Phone
944-4433Phone
944-5404Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.